Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


Controlled Release

18 Mar 2013 - 19 Mar 2013 - London, UK



Bookmark and Share


SMi presents its 10th annual conference on . . .

Controlled Release – the only conference in Europe to focus specifically on controlled release.

At this well-established annual event you will hear, from the global expert speaking faculty, how controlled release products and drugs have developed over the past 12 months.  

ATTEND TO:

• Discover the very latest developments in this innovative and booming industry

• New for 2013:

- Investigating structure-activity relationships of siRNA nanoparticles

- Challenges of pre-clinical gastro-retentive dosage form development

- Numerous case studies from big pharma laboratories – such as GSKs formulation development programme

• Benefit from an interactive half-day post-conference workshop on SMART formulation design: tools and strategies for complex formulation design and problem solving

KEY SPEAKERS INCLUDE:

Michael Keller, PDU Parenteral, Topical & siRNA Lead, Novartis

Andy Lewis, Director, Ipsen

Petra Wicklandt, CMC Development, Merck

Howard Stevens, Professor, Exploratory Drug Discovery, University of Strathclyde

David Elder, Externalisation Director, GlaxoSmithKline

Monica Rosa, Director, SigmoidPharma

Navnit Shah, Distinguished Scientist, Roche

Mark Wilson, Director, Collaboration Management, GlaxoSmithKline

Dmitry Samarsky, Technology & Business Development, Ribobio

Richard Elkes, Senior Research Scientist, Merck 

and many more . . .

Click here for the programme, full speaker line-up and to register http://www.smi-online.co.uk/goto/controlledrelease27.asp 



Further information
Scientific News
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Viable HIV Vaccine Confirmed by Study
HIV Study in macaques confirms clinically viable vaccine opening the way for future treatment in humans.
PREVAIL Treatment Trial for Men with Persistent Ebola Viral RNA
The six-month study will enroll 60 to 120 EVD survivors.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!